Inxight Drugs

U.S. Department of Health & Human Services Divider Arrow

National Institutes of Health Divider Arrow

NCATS

This repository is under review for potential modification in compliance with Administration directives.

Return Home Inxight Drugs

Home
Browse Drugs
Search
- Structure Search
- Sequence Search
Downloads
About

Show Filters

Hide Filters

Condition

Loiasis

3

Unknown

2,596

Pain

619

Cancer

609

Hypertension

575

All Match

Any Match

Exclude Selected

Exclude Selected

Development Status

US Previously Marketed

3

All Match

Any Match

Exclude Selected

Exclude Selected

Highest Phase

Approved

3

All Match

Any Match

Exclude Selected

Exclude Selected

Approval Year

1950

3

All Match

Any Match

Exclude Selected

Exclude Selected

Treatment Modality

Curative

3

All Match

Any Match

Exclude Selected

Exclude Selected

Substance Class

Chemical

3

All Match

Any Match

Exclude Selected

Exclude Selected

Code System

CAS

3

EPA CompTox

3

FDA UNII

3

PUBCHEM

3

CFR

2

All Match

Any Match

Exclude Selected

Exclude Selected

ATC Level 1

ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS

1

All Match

Any Match

Exclude Selected

Exclude Selected

ATC Level 2

ANTHELMINTICS

1

All Match

Any Match

Exclude Selected

Exclude Selected

ATC Level 3

ANTINEMATODAL AGENTS

1

All Match

Any Match

Exclude Selected

Exclude Selected

ATC Level 4

Piperazine and derivatives

1

All Match

Any Match

Exclude Selected

Exclude Selected

Substance Form

Salts, Hydrates, Esters, etc.

2

Principal Form

1

All Match

Any Match

Exclude Selected

Exclude Selected

Showing 1 - 3 of 3 results

First page disabled
Previous page disabled
1
Next page disabled
Next page disabled

DIETHYLCARBAMAZINE

V867Q8X3ZD

Export Data
Search for Structure

Status:

US Previously Marketed

First approved in 1950

Class (Stereo):

CHEMICAL (ACHIRAL)

Conditions:

Tropical pulmonary eosinophilia

Lymphatic filariasis

Diethylcarbamazine is used in humans, dogs and cats for the treatment of parasitic infections, including pulmonary eosinophilia, loiasis, and lymphatic filariasis. The exact mechanism of its action is unknown, however some studies showed the involvme...

nt of inducible nitric-oxide synthase and the cyclooxygenase pathway. Although there is no information on whether the drug is marketed in the USA and Europe, it is currently used in India.

DIETHYLCARBAMAZINE CITRATE

OS1Z389K8S

Export Data
Search for Structure

Status:

US Previously Marketed

First approved in 1950

Class (Stereo):

CHEMICAL (ACHIRAL)

Conditions:

Tropical pulmonary eosinophilia

Lymphatic filariasis

Diethylcarbamazine is used in humans, dogs and cats for the treatment of parasitic infections, including pulmonary eosinophilia, loiasis, and lymphatic filariasis. The exact mechanism of its action is unknown, however some studies showed the involvme...

nt of inducible nitric-oxide synthase and the cyclooxygenase pathway. Although there is no information on whether the drug is marketed in the USA and Europe, it is currently used in India.

DIETHYLCARBAMAZINE PAMOATE

X8816G8TOP

Export Data
Search for Structure

Status:

US Previously Marketed

First approved in 1950

Class (Stereo):

CHEMICAL (ACHIRAL)

Conditions:

Tropical pulmonary eosinophilia

Lymphatic filariasis

Diethylcarbamazine is used in humans, dogs and cats for the treatment of parasitic infections, including pulmonary eosinophilia, loiasis, and lymphatic filariasis. The exact mechanism of its action is unknown, however some studies showed the involvme...

nt of inducible nitric-oxide synthase and the cyclooxygenase pathway. Although there is no information on whether the drug is marketed in the USA and Europe, it is currently used in India.

HHS VULNERABILITY DISCLOSURE

For language access assistance, contact the NCATS Public Information Officer

National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966


			version 1.1